HHS Issues Funding Opportunity Announcement for Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases
Grants
Copyright © Targeted News Service, 2020
Copyright © Targeted News Service, 2020
2020-09-16
by MYRA TUGADE
WASHINGTON, Sept. 16 -- The U.S. Department of Health and Human Services' National Institutes of Health issued a funding opportunity announcement for clinical trials of drugs targeting shared molecular etiologies in multiple rare diseases.
The agency description of the funding opportunity announcement states: "The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease.
WASHINGTON, Sept. 16 -- The U.S. Department of Health and Human Services' National Institutes of Health issued a funding opportunity announcement for clinical trials of drugs targeting shared molecular etiologies in multiple rare diseases.
The agency description of the funding opportunity announcement states: "The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease.
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com